mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.02 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |